Lorenzo D'Ambrosio

9PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 02, 2024
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.

Federica Galvagno, Valeria Leuci, Annamaria Massa

|Sep 27, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells.

Ramona Rotolo, Valeria Leuci, Chiara Donini

|Sep 23, 2022
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.

Erika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio

|Sep 09, 2020
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes.

Valeria Leuci, Chiara Donini, Giovanni Grignani

|Aug 09, 2020
Reply to Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals.

Lorenzo D'Ambrosio, Saskia Litière, Silvia Stacchiotti

Pageof 2